Hemanext ONE® was carefully designed with focus on patients’ well-being and needs. It has the potential to benefit all patients requiring transfusions. Learn more: https://lnkd.in/eAdKTMsW #Hemanext #HemanextONE #Transfusions
About us
Hemanext is a medical technology company with headquarters and R&D Center of Excellence in Lexington MA, and manufacturing operations in Avon MA. Hemanext is committing its resources to the continuing effort of the transfusion medicine community to save lives and improve patient outcomes. Our distinctive focus is on innovations in systems enabling blood collection, processing, storage and transfusion that will promote dramatic improvements in transfusion therapies. For more information, visit www.hemanext.com.
- Website
-
http://www.hemanext.com
External link for Hemanext
- Industry
- Medical Equipment Manufacturing
- Company size
- 51-200 employees
- Headquarters
- Lexington, Massachusetts
- Type
- Privately Held
Locations
-
Primary
Get directions
99 Hayden Ave
Lexington, Massachusetts 02421, US
Employees at Hemanext
-
Andrew Dunham
-
Martin Cannon
Founder & former President and CEO (retired) at Hemanext, Inc. Medical Device Technology Firm
-
Attila Kiss
Medical device engineer with experience in product development, sustaining engineering, and project management
-
Art McCarthy
Experienced Operations Leader
Updates
-
Hypoxic storage has been shown to reduce effects of oxidative damage. It reduces oxyhemoglobin formation and reduces subsequent oxidative reactions. Learn more: https://lnkd.in/giDPE4hC #hemanext #HypoxicStorage
-
#HemanextONE protects the quality, functionality, and viability of #RBCs by processing and storing them in a low-oxygen (#hypoxic) state. Learn how Hemanext ONE protects RBCs during storage: https://lnkd.in/eAdKTMsW
Hemanext ONE - Hemanext
https://hemanext.com
-
Our vision is to transform #transfusion medicine worldwide through advances in biomedical technology. Learn more: https://lnkd.in/dPgJG8jh #hemanext #TransfusionMedicine
About - Hemanext
https://hemanext.com
-
Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food & Drug Administration. Learn more: https://lnkd.in/eAdKTMsW #Hemanext #HemanextOne #Transfusions
Hemanext ONE - Hemanext
https://hemanext.com
-
Help support #transfusion patients by donating #blood this month! Find a #blood drive or locate the closest donation center: https://rdcrss.org/2Tibnah #Hemanext #PatientAdvocacy #BloodDonation
-
-
#HemanextONE delivers the first meaningful innovation in #RBC processing and storage in decades. Learn more: https://lnkd.in/eAdKTMsW Hemanext ONE has been granted marketing authorization for commercial distribution via the De Novo process by the U.S. Food & Drug Administration and has CE Mark Certification for the EU.
Hemanext ONE - Hemanext
https://hemanext.com
-
#DidYouKnow Hypoxic storage has been proven to mitigate the RBC storage lesion by limiting the effects of oxygen. Learn more: https://lnkd.in/giDPE4hC #hemanext #HypoxicStorage #HypoxicRBCs #StorageLesion
-
What is the Storage Lesion? The #StorageLesion refers to the collection of changes that occur to red blood cells (#RBCs) during storage See how RBCs affected by the storage lesion impact the body: https://lnkd.in/dcX--c8 #hemanext
Storage Lesion - Hemanext
https://hemanext.com
-
#StorageLesions on red blood cells are a result of oxidative damage during storage. Hemanext ONE® Red Blood Cell (RBC) Processing and Storage system's goal is to reduce the degradation and improve the function of an #RBC by removing the root cause. Learn more about Hemanext ONE: https://lnkd.in/eAdKTMsW Learn more about storage lesion: https://lnkd.in/dcX--c8 #Hemanext #HemanextONE
Storage Lesion - Hemanext
https://hemanext.com